Vimarsana
Biggest News Aggregation in the World

Ramez Eskander News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ramez Eskander. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ramez Eskander Today - Breaking & Trending Today

Priority Review Granted to Keytruda Combo for Endometrial Cancer - Vimarsana News

Priority Review Granted to Keytruda Combo for Endometrial Cancer

Keytruda plus chemotherapy has been granted a priority review by the FDA to treat certain patients with endometrial cancer.

Gynecologic cancer patients and advocates unite at FWC Forum in San Diego - Vimarsana News

Gynecologic cancer patients and advocates unite at FWC Forum in San Diego

The Foundation for Women's Cancer (FWC) is pleased to host a Patient and Advocate Education Forum on​​ Friday, March 15, 2024, 10 a.m. – 4:30 p.m. PT, in San Diego, CA, at the San Diego Convention Center the day before the start of the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women's Cancer.

The Foundation for Women's Cancer to Host Free Patient and Advocates Education Forum in San Diego - Vimarsana News

The Foundation for Women's Cancer to Host Free Patient and Advocates Education Forum in San Diego

The Foundation for Women’s Cancer (FWC) is pleased to host a free Patient and Advocate Education Forum on​​ Friday, March 15, 2024, 10 a.m. – 4:30 p.m.

The Future of Clinical Care for Patients With Advanced Endometrial Cancer - Vimarsana News

The Future of Clinical Care for Patients With Advanced Endometrial Cancer

Closing their conversation, Ramez Eskander, MD, and Krishnansu Tewari, MD, share how they envision the future treatment landscape for patients with advanced endometrial cancer.

Patient Profile Presentation: A 64-Year-Old Woman With Recurrent Endometrial Cancer - Vimarsana News

Patient Profile Presentation: A 64-Year-Old Woman With Recurrent Endometrial Cancer

Ramez Eskander, MD, presents the profile of a 64-year-old postmenopausal woman diagnosed with recurrent endometrial carcinoma for discussion.